---
figid: PMC6025395__cancers-10-00183-g001
figtitle: Differential phospho-Smad signals between tumor suppression and fibrocarcinogenesis
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6025395
filename: cancers-10-00183-g001.jpg
figlink: /pmc/articles/PMC6025395/figure/cancers-10-00183-f001/
number: F1
caption: Differential phospho-Smad signals between tumor suppression and fibrocarcinogenesis.
  (A) Activated transforming growth factor (TGF)-β type I receptor (TβRI) phosphorylates
  COOH-tail serine residues of Smad2 and Smad3. Both COOH-terminally phosphorylated
  Smad2/3 (pSmad2C and pSmad3C) translocate with Smad4 to the nuclei of quiescent
  hepatocytes after regeneration. Smad2/3/4, complex binds the p21waf1 promoter and
  suppresses cell growth; (B) Pro-inflammatory cytokines (CK) such as tumor necrosis
  factor-α activate c-Jun N-terminal kinase (JNK), which phosphorylates the linker
  regions of Smad2 and Smad3. Linker phosphorylated Smad3 (PSmad3L) translocates with
  Smad4 to the nucleus and binds plasminogen activator inhibitor type 1 (PAI-1) promoter.
  Linker phosphorylated Smad2 (PSmad2L) is localized in the cytoplasm, and Smad2 translocates
  to the nucleus only after COOH-tail phosphorylation by TβRI. PSmad2L/C in cooperation
  with pSmad3L and Smad4 stimulate PAI-1 transcription and extracellular matrix (ECM)
  deposition. PSmad3L up-regulates c-Myc and stimulates cell growth, while suppressing
  the pSmad3C-mediated tumor suppressive pathway.
papertitle: Clinico-Pathological Importance of TGF-β/Phospho-Smad Signaling during
  Human Hepatic Fibrocarcinogenesis.
reftext: Katsunori Yoshida, et al. Cancers (Basel). 2018 Jun;10(6):183.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9065663
figid_alias: PMC6025395__F1
figtype: Figure
redirect_from: /figures/PMC6025395__F1
ndex: 3f8b9cf6-dee6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6025395__cancers-10-00183-g001.html
  '@type': Dataset
  description: Differential phospho-Smad signals between tumor suppression and fibrocarcinogenesis.
    (A) Activated transforming growth factor (TGF)-β type I receptor (TβRI) phosphorylates
    COOH-tail serine residues of Smad2 and Smad3. Both COOH-terminally phosphorylated
    Smad2/3 (pSmad2C and pSmad3C) translocate with Smad4 to the nuclei of quiescent
    hepatocytes after regeneration. Smad2/3/4, complex binds the p21waf1 promoter
    and suppresses cell growth; (B) Pro-inflammatory cytokines (CK) such as tumor
    necrosis factor-α activate c-Jun N-terminal kinase (JNK), which phosphorylates
    the linker regions of Smad2 and Smad3. Linker phosphorylated Smad3 (PSmad3L) translocates
    with Smad4 to the nucleus and binds plasminogen activator inhibitor type 1 (PAI-1)
    promoter. Linker phosphorylated Smad2 (PSmad2L) is localized in the cytoplasm,
    and Smad2 translocates to the nucleus only after COOH-tail phosphorylation by
    TβRI. PSmad2L/C in cooperation with pSmad3L and Smad4 stimulate PAI-1 transcription
    and extracellular matrix (ECM) deposition. PSmad3L up-regulates c-Myc and stimulates
    cell growth, while suppressing the pSmad3C-mediated tumor suppressive pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ck
  - dpp
  - gbb
  - put
  - mav
  - bsk
  - Myc
  - Bri
  - TGFB1
  - TGFB2
  - TGFB3
  - TGFBR1
  - MAPK8
  - MAPK9
  - MAPK10
  - SERPINE1
  - MYC
  - ITM2B
---
